Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
07/2006
07/05/2006CN1796365A Method for synthesizing amide of mint
07/05/2006CN1262535C Method for synthesizing S-(1)-2.2 dimethylcyclopropane formamide
07/05/2006CN1262534C Process for preparing N-acetyl-L-tyrosine
07/04/2006US7071359 Neuropathy improvers containing nitrogenous compounds as the active ingredient
07/04/2006US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides
07/04/2006US7071219 For therapy of diseases mediated by the inhibition of histone deacetylase, such as cancer
07/04/2006US7071214 Compounds and compositions for delivering active agents
06/2006
06/29/2006WO2006067450A2 Modulator
06/29/2006WO2006067430A1 2-amino-1-phenylethylcarboxamide derivatives
06/29/2006WO2006067423A1 Glycine transport inhibitors
06/29/2006WO2006067417A1 Glycine transport inhibitors
06/29/2006WO2006067416A1 Chemical processes and intermediates
06/29/2006WO2006067414A2 Glycine transport inhibitors
06/29/2006WO2006067412A1 Chemical processes for the preparation of a colchinol derivative and intermediates
06/29/2006WO2006066978A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics
06/29/2006WO2006066779A1 Novel cyclohexane derivatives
06/29/2006WO2005072246A3 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/29/2006US20060142244 Geranyl compounds
06/29/2006US20060140996 Vermin-repellant compositions and compounds
06/29/2006CA2592467A1 Glycine transport inhibitors
06/29/2006CA2592382A1 Modulator
06/29/2006CA2590246A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics
06/28/2006EP1674447A1 Amides, polyolefin resin compositions, and moldings
06/28/2006EP1673082A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
06/28/2006EP1516041B1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
06/28/2006EP1268405B1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents
06/28/2006CN1795169A Crystalline form of beta2 adrenergic receptor agonist
06/28/2006CN1795167A Method for continuously producing alkylamino(meth)acrylamides
06/28/2006CN1793111A Process for recovering dimethyl formyl amide from waste water
06/27/2006US7067697 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy
06/27/2006US7067554 Method for the synthesis of compounds of formula I and their uses thereof
06/27/2006US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase
06/27/2006US7067471 Addition reacting a fatty acid monoisopropanolamide with propylene oxide or propylene oxide adduct to form polyoxypropylene fatty acid isopropanolamide surfactant with an oxazolines by-product, heat treating and hydrolyzing the oxazoline compound to reduce by-product, collecting refined surfactant
06/27/2006US7067119 Using polypeptides
06/27/2006CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators
06/22/2006WO2006066031A1 Durable coating compositions containing novel aspartic amine compounds
06/22/2006WO2006063999A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/22/2006WO2006063821A1 Manufacture process of n-substituted salicylamides
06/22/2006WO2006063697A1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
06/22/2006US20060135620 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
06/22/2006US20060135613 Carboxamides derivatives
06/22/2006US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid
06/22/2006US20060135480 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
06/22/2006US20060134130 Oral drug delivery compositions and methods
06/22/2006DE102004059725A1 2-Alkyl-cycloalk(en)yl-carboxamide 2-alkyl-cycloalk (en) yl-carboxamides
06/22/2006CA2590330A1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
06/22/2006CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/22/2006CA2587213A1 Manufacture process of n-substituted salicylamides
06/21/2006EP1671958A1 Method of producing amide compound
06/21/2006EP1671941A1 Substituted benzanilide compound and pest control agent
06/21/2006EP1670849A1 Aspartate derivatives and process for their preparation
06/21/2006EP1670807A1 Fluorescent labeled sphingosines
06/21/2006EP1670763A1 Cyclopentene compounds
06/21/2006EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists
06/21/2006EP1670310A1 Capsaicin derivates and the production and use thereof
06/21/2006EP1272147B1 Dental materials with extendable work time, kits, and methods
06/21/2006EP1146037B1 Process for the preparation of optically active amino alcohols
06/21/2006EP1100770B1 Monomers and network polymers obtained therefrom
06/21/2006EP1049662B1 Inhibitors of alpha4 mediated cell adhesion
06/21/2006EP0957080B1 Novel ethylamine derivatives
06/21/2006CN1791576A Benzamide modulators of metabotropic glutamate receptors
06/21/2006CN1791569A Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof
06/20/2006US7064232 Hydrophobic modified diquaternary monomers and polymers as thickening agents of acidic aqueous compositions
06/20/2006US7064229 Succinic acid derivatives
06/20/2006US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
06/20/2006CA2259183C Fluorous reaction and separation systems
06/15/2006WO2006062978A1 Method for preparing n-phenylpyrazole-1-carboxamides
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides
06/15/2006WO2006061159A1 Method for the production of n,n-dimethylacetamide (dmac)
06/15/2006WO2006061157A1 Method for the production of n,n-dimethylacetamide (dmac)
06/15/2006WO2006061153A1 Method for producing n,n-dimethylacetamide (dmac)
06/15/2006WO2006017045A3 Formation of tetra-substituted enamides and stereoselective reduction thereof
06/15/2006WO2006010775A8 Tyrosine derivatives as ppar-gamma-modulators
06/15/2006US20060128973 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes
06/15/2006US20060128972 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents
06/15/2006US20060128948 obtained by modifying carboxyl groups of biological low-molecular-weight compounds having two or more carboxyl groups with N-hydroxysuccinimide, N-hydroxysulfosuccinimide; used to treat medical devices and the like are non-natural, artificially synthesized products; low toxicity and easily assimilated
06/15/2006US20060128786 Compounds for the treatment of alzheimer's disease
06/15/2006US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists
06/15/2006US20060128633 Colchinol derivatives as vascular damaging agents
06/15/2006CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/14/2006EP1669345A1 Ester derivative and medicinal use thereof
06/14/2006EP1667965A2 Bridged macrocyclic module compositions
06/14/2006EP1667959A1 Biphenyloxy-acids
06/14/2006EP1667958A2 Melanin concentrating hormone antagonists
06/14/2006EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor
06/14/2006EP1209185B1 Diaminobenzene derivative, polyimide obtained therefrom, and liquid-crystal alignment film
06/14/2006EP1102742B1 Compounds and compositions for delivering active agents
06/14/2006DE102004059219A1 Pyrazindicarbonsäureamide und ihre Verwendung Pyrazindicarbonsäureamide and their use
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/14/2006CN1259306C Process for the preparation of aminoalcohol, aminoalcohol derivatives and their further conversion to (1S, 4R)-4-(2-AMINO - 6-CHLORO - 9- H - PURINE - 9-YL)-2- CYCLOPENTENYL-1-METHANOL or its salt
06/13/2006US7060856 Kinase inhibitors; dissolving in water, alcohol mixture; cooling; solvent extraction
06/13/2006US7060803 Metal complex-protein composite and hydrogenation catalyst
06/13/2006US7060776 Crosslinked, water insoluble matrix; electrophoresis membranes
06/13/2006CA2219278C Methods of making (s)-3-(aminomethyl)-5-methylhexanoic acid
06/08/2006WO2006058698A1 Method for purifying polar vinyl compounds
06/08/2006WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
06/08/2006WO2005007810A3 Functional synthetic molecules and macromolecules for gene delivery